Biointron is excited to announce our participation in Antibody Engineering & Therapeutics US 2025, set to take place December 14-17, 2025, in San Diego, California. This globally acclaimed conference serves as a critical platform for advancing the science of antibodies, bringing together industry leaders, academic researchers, and innovators to discuss emerging trends and groundbreaking research.
As part of the event, Biointron will not only exhibit our cutting-edge antibody engineering technologies but also participate in discussions addressing key challenges in therapeutic development. From enhancing antibody specificity and functionality to expediting discovery pipelines, we aim to demonstrate the tangible impact of our innovations in transforming therapeutic outcomes. Our team will be available to provide deep dives into our ongoing projects and discuss potential applications with attendees.
For Biointron, Antibody Engineering & Therapeutics 2025 is more than a showcase—it's an opportunity to engage with the broader biopharma community. We invite researchers, collaborators, and industry professionals to connect with us, share ideas, and explore the future of antibody therapeutics together. Join us at this event as we work toward redefining the boundaries of antibody science and improving healthcare worldwide.
For more details about the event, please visit the Antibody Engineering & Therapeutics US 2025 website [https://informaconnect.com/antibody-engineering-therapeutics/]
Time: December 14-17, 2025
Location: Marriott Marquis San Diego | San Diego, CA
Booth: #TBD
